A small group of members met in London to review ongoing projects, consider EU funding opportunities and brainstorm areas where the collaboration would make biggest potential impact. There is much we will achieve as a group which wouldn’t otherwise be possible. Analyses of exposures within rare cancers (and subgroups of common common cancers) will be one of these key areas. There are exciting times ahead as we develop our analysis infrastructure, education/mentioning and are keen to expand the network into new countries. Please contact us if you are interested in participating.